(Q36244049)

13 August 2017

Effectiveness of oral iron to manage anemia in long-term hemodialysis patients with the use of ultrapure dialysate (English)

1 reference

13 August 2017

Akiyasu Tsuchida

1

1 reference

13 August 2017

Bishnuhari Paudyal

2

1 reference

13 August 2017

Pramila Paudyal

3

1 reference

13 August 2017

Yoshitaka Ishii

4

1 reference

13 August 2017

Keiju Hiromura

5

1 reference

13 August 2017

Yoshihisa Nojima

6

1 reference

13 August 2017

Minoru Komai

7

1 reference

13 August 2017

20 July 2010

1 reference

Experimental and Therapeutic Medicine

13 August 2017

1 reference

13 August 2017

1

1 reference

13 August 2017

5

1 reference

13 August 2017

777-781

1 reference

An update on iron physiology.

13 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3445869

Baseline characteristics of an incident haemodialysis population in Spain: results from ANSWER--a multicentre, prospective, observational cohort study

1 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3445869

Intravenous versus oral iron supplementation for the treatment of anemia in CKD: systematic review and meta-analysis

1 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3445869

Ferric gluconate reduces epoetin requirements in hemodialysis patients with elevated ferritin

1 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3445869

Appraisal of evidence and control of bias in the kidney disease outcomes quality initiative guideline development process

1 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3445869

Hepcidin in anemia and inflammation in chronic kidney disease.

1 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3445869

Iron management in end-stage renal disease

1 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3445869

Bacterial transferrin receptors ? structure, function and contribution to virulence

1 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3445869

Neutrophil impairment associated with iron therapy in hemodialysis patients with functional iron deficiency

1 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3445869

An overview of regular dialysis treatment in Japan (as of 31 December 2007).

29 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3445869

A Randomized Controlled Trial of Oral versus Intravenous Iron in Chronic Kidney Disease

22 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3445869

The influence of hepatitis C and iron replacement therapy on plasma pentosidine levels in haemodialysis patients.

22 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3445869

Serum ferritin in chronic kidney disease: reconsidering the upper limit for iron treatment.

22 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3445869

Effect of malnutrition-inflammation complex syndrome on EPO hyporesponsiveness in maintenance hemodialysis patients

22 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3445869

A randomized study of oral vs intravenous iron supplementation in patients with progressive renal insufficiency treated with erythropoietin.

22 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3445869

Comparison of intravenous iron sucrose to oral iron in the treatment of anemic patients with chronic kidney disease not on dialysis

22 September 2018

1 reference

12 December 2020

Enhanced oxidative stress in haemodialysis patients receiving intravenous iron therapy

1 reference

12 December 2020

Ferric gluconate is highly efficacious in anemic hemodialysis patients with high serum ferritin and low transferrin saturation: results of the Dialysis Patients' Response to IV Iron with Elevated Ferritin (DRIVE) Study

1 reference

12 December 2020

Quality of water and dialysate in haemodialysis

1 reference

12 December 2020

Intravenous administration of iron in epoetin-treated haemodialysis patients--which drugs, which regimen?

1 reference

12 December 2020

Iron administration and clinical outcomes in hemodialysis patients

1 reference

12 December 2020

Role of oral iron in the management of long-term hemodialysis patients

1 reference

12 December 2020

Liver iron accumulation in patients with chronic active hepatitis C: prevalence and role of hemochromatosis gene mutations and relationship with hepatic histological lesions

1 reference

12 December 2020

Iron Metabolism in Patients with Chronic Renal Failure

1 reference

12 December 2020

Efficacy of oral iron therapy in patients receiving recombinant human erythropoietin

1 reference

12 December 2020

Identifiers

DOI

10.3892/ETM.2010.122

1 reference

13 August 2017

1 reference

13 August 2017

1 reference